TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.
To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with TRIPALMITIN
| MeSH term | MeSH ID | Detail |
|---|---|---|
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Respiratory Distress Syndrome, Newborn | D012127 | 5 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| HIV-Associated Lipodystrophy Syndrome | D039682 | 3 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
| Gene | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Potta SG et al. | Development of solid lipid nanoparticles for enhanced solubility of poorly soluble drugs. | 2010 | J Biomed Nanotechnol | pmid:21361127 |
| Windbergs M et al. | Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping. | 2010 | J Pharm Sci | pmid:19691104 |
| Windbergs M et al. | Two-step solid lipid extrusion as a process to modify dissolution behavior. | 2010 | AAPS PharmSciTech | pmid:20309654 |
| Son JM et al. | Optimisation of tripalmitin-rich fractionation from palm stearin by response surface methodology. | 2010 | J. Sci. Food Agric. | pmid:20549806 |
| Fulda S et al. | Cellular stress responses: cell survival and cell death. | 2010 | Int J Cell Biol | pmid:20182529 |
| HolÄapek M et al. | Regioisomeric analysis of triacylglycerols using silver-ion liquid chromatography-atmospheric pressure chemical ionization mass spectrometry: comparison of five different mass analyzers. | 2010 | J Chromatogr A | pmid:21075380 |
| de Paula AV et al. | Screening of food grade lipases to be used in esterification and interesterification reactions of industrial interest. | 2010 | Appl. Biochem. Biotechnol. | pmid:19263247 |
| Legrand P et al. | Short chain saturated fatty acids decrease circulating cholesterol and increase tissue PUFA content in the rat. | 2010 | Lipids | pmid:20924709 |
| Seetapan N et al. | Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency. | 2010 | Drug Dev Ind Pharm | pmid:20184417 |
| Windbergs M et al. | Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures. | 2009 | J Control Release | pmid:19358867 |
| Windbergs M et al. | Influence of structural variations on drug release from lipid/polyethylene glycol matrices. | 2009 | Eur J Pharm Sci | pmid:19406229 |
| Helgason T et al. | Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). | 2009 | J Colloid Interface Sci | pmid:19380149 |
| Windbergs M et al. | Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution. | 2009 | Eur J Pharm Biopharm | pmid:18588976 |
| Mansour HM et al. | Nanomedicine in pulmonary delivery. | 2009 | Int J Nanomedicine | pmid:20054434 |
| Sol ER et al. | Proteins altered by elevated levels of palmitate or glucose implicated in impaired glucose-stimulated insulin secretion. | 2009 | Proteome Sci | pmid:19607692 |
| Royter M et al. | Thermostable lipases from the extreme thermophilic anaerobic bacteria Thermoanaerobacter thermohydrosulfuricus SOL1 and Caldanaerobacter subterraneus subsp. tengcongensis. | 2009 | Extremophiles | pmid:19579003 |
| Kuo YC and Lin CW | Effect of electromagnetic field and surface modification on the electrical behavior of novel solid lipid nanoparticles covered with l-arginine. | 2009 | Colloids Surf B Biointerfaces | pmid:19181492 |
| Mukherjee S et al. | Solid lipid nanoparticles: a modern formulation approach in drug delivery system. | 2009 | Indian J Pharm Sci | pmid:20502539 |
| Logan JW and Moya FR | Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials. | 2009 | Ther Clin Risk Manag | pmid:19436610 |
| Hellemans KH et al. | Susceptibility of pancreatic beta cells to fatty acids is regulated by LXR/PPARalpha-dependent stearoyl-coenzyme A desaturase. | 2009 | PLoS ONE | pmid:19787047 |